Tuesday, November 7, 2023
3:00 PM – 4:00 PM (EST)
No registration is required to participate - the Series is free and open to anyone. To participate, log in with your ASCO.org username and password. Create a new, free account or for assistance with your existing login.
Tanios Bekaii-Saab, MD - Moderator
Mayo Clinic, Arizona
Welcome and Introduction
Samuel Klempner, MD, FASCO
Massachusetts General Hospital
Exploring Gastroesophageal Cancer: A Deep Dive into Innovative Therapies
Yelena Y. Janjigian, MD
Memorial Sloan Kettering Cancer Center
Abstract 433248: EDGE-Gastric Arm A1: Phase 2 study of domvanalimab, zimberelimab, and FOLFOX in first-line (1L) advanced gastroesophageal cancer.
Rui-Hua Xu, MD, PhD
Sun Yat-sen University Cancer Center
Abstract 434420: A phase 1 trial of claudin 18.2-specific antibody-drug conjugate CMG901 in patients with advanced gastric/gastroesophageal junction cancer.
Elizabeth Smyth, MD
Oxford University Hospitals NHS Foundation Trust
Discussion of Abstracts 433248 and 434420
Panel Question and Answer with Drs. Klempner, Janjigian, Xu, and Smyth, moderated by Dr. Tanios Bekaii-Saab